A detailed history of Invst, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Invst, LLC holds 11,346 shares of AMPH stock, worth $318,368. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,346
Previous 14,390 21.15%
Holding current value
$318,368
Previous $698,000 39.68%
% of portfolio
0.05%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 19, 2025

SELL
$36.84 - $53.4 $112,140 - $162,549
-3,044 Reduced 21.15%
11,346 $421,000
Q3 2024

Nov 19, 2024

BUY
$36.99 - $50.09 $101,796 - $137,847
2,752 Added 23.65%
14,390 $698,000
Q2 2024

Aug 16, 2024

BUY
$38.65 - $43.48 $226,373 - $254,662
5,857 Added 101.31%
11,638 $465,000
Q1 2024

May 24, 2024

BUY
$42.85 - $63.45 $247,715 - $366,804
5,781 New
5,781 $253,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.38B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.